A public body that develops and provides guidance to UK healthcare professionals and others, to ensure that the care they provide is of the best possible quality and offers the best value for money.
Adults with thalassemia, a severe genetic blood disorder, will be offered potentially curative stem cell transplants on the NHS for the first time...
The rising cost of living and lack of affordable treatments are pricing fertility patients out of becoming parents, a national charity has said...
The significant price-tags associated with gene therapies are leading to questions being raised about value for both patients and payers...
The UK government has launched a survey seeking women's views on reproductive health issues, including fertility services...
The UK National Institute for Health and Care Excellence (NICE) has published draft guidance recommending against the use of a new gene therapy for haemophilia B on the NHS...
The Government said in its Women's Health Strategy that it was 'committed to greater transparency of the provision of IVF services across the country and will therefore explore mechanisms to publish data nationally on provision and availability of IVF'...
GPs should use their 'soft influence' to lobby commissioners for better fertility treatment, the president of the Royal College of GPs said at an event hosted by PET...
Following its report 'The Power of Three IVF Cycles', PET held a wide-ranging discussion with seven experts, to discuss the funding and provision of fertility treatment and what is meant by a 'full' cycle of IVF...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
